Keyphrases
Aberrations
36%
Bcl-2 Family
35%
Cas9 Protein
20%
Cell Population
17%
Cell-based
20%
Checkpoint Kinase 1 (CHK1)
17%
Chromosomal Deletion
17%
Chromosome 11q
22%
Chromosome 1q
17%
Chromosome-specific
17%
Cisplatin Resistance
35%
Copy number Gain
35%
Feeder-free Culture
17%
Genetic Aberrations
36%
Germ Cell Malignancy
17%
Germ Cell Tumor
69%
Human Germ Cells
22%
Human Pluripotent Stem Cells (hPSCs)
48%
Large Deletion
17%
Loss Amplification
17%
Low Amplitude
35%
Malignant Germ Cell Tumors
29%
MCM9
17%
Mediastinal Germ Cell Tumor
35%
MEK Inhibitor (MEKi)
40%
Murine Double Minute 4 (MDM4)
17%
MYCN Amplification
17%
Neuroblastoma
84%
Neuroblastoma Cell Line
18%
Oncogene
38%
Pathway mutation
17%
Pediatric Cancer
17%
Pluripotent
20%
Pluripotent Stem Cells
25%
RAS-MAPK
35%
RAS-MAPK Pathway
56%
Refractory Neuroblastoma
27%
Safety Issues
17%
Selective Advantage
21%
Somatic Malignancy
17%
Stem Cell-derived
20%
Targeted Drugs
17%
Teratoma
23%
Therapeutic Vulnerabilities
39%
Trametinib
28%
Tumor
50%
Tumor Progression
17%
Tumor Protein p53 (TP53)
42%
Tumor Risk
17%
Tumor Subtype
26%
Biochemistry, Genetics and Molecular Biology
Adolescence
8%
Alpha-Fetoprotein
8%
Aneuploidy
17%
Autosome
8%
Carcinogenesis
8%
Chromosomal Aberration
20%
Chromosome 11q
26%
Chromosome 12
7%
Chromosome 12 (Human)
7%
Chromosome 1q
17%
Chromosome 6
10%
Chromosome 6q
8%
Cisplatin
35%
Clonal Variation
8%
Clonality
8%
Colony Forming Unit S
8%
CRISPR
7%
CRISPR/Cas9
20%
DNA Methylation
8%
DNA Repair
10%
Drug Resistance
7%
Drug Sensitivity
7%
Embryonic Stem Cell
17%
Functional Genomics
8%
Gene Drive
7%
Genetics
34%
Genomics
19%
Germ Cell
59%
Germline
17%
Growth, Development and Aging
8%
Human Chorionic Gonadotropin
8%
Kinase
17%
MDM4
17%
Mitogen-Activated Protein Kinase
35%
Neuroendocrine Cell
17%
Oncogene
35%
Overall Survival
7%
P53
13%
Pan-cancer
7%
Phosphotransferase
17%
Polyploid
8%
RNA Sequence
8%
Stem Cell
81%
Stem Cell Transplantation
23%
Synteny
14%
Teratoma
25%
Trisomy
10%
Tumor Marker
8%
Tumor Progression
17%
Vitronectin
8%
Medicine and Dentistry
Biological Marker
8%
Cancer
39%
Carcinogenesis
8%
Cell Population
17%
Checkpoint Kinase 1
17%
Chemotherapy
6%
Chromosome 11q
17%
Chromosome 3p
5%
Cisplatin
41%
Clinical Trial
5%
Dentigerous Cyst
13%
Diagnosis
8%
Disease
17%
Diseases
9%
Embryonal Carcinoma
5%
Endodermal Sinus Tumor
12%
Ganglioneuroblastoma
35%
Gene Expression
5%
Genetic Screening
5%
Germinoma
100%
Heat Map
8%
Human Pluripotent Stem Cell
8%
In Vitro
6%
Knock Out
5%
Leiomyosarcoma
6%
Lethality
17%
Malignant Neoplasm
13%
Mediastinal Germ Cell Tumor
25%
microRNA
5%
Minimal Residual Disease
5%
Mitogen-Activated Protein Kinase
17%
Neoplasm
59%
Overall Survival
5%
Pediatric Cancer
17%
Pediatrics
8%
Pluripotent Stem Cell
53%
Primary Tumor
10%
Protein P53
7%
Recurrent Disease
17%
Safety Assessment
5%
Solid Malignant Neoplasm
8%
Somatics
17%
Stem Cell Therapy
22%
Testis Cancer
5%
Translational Research
5%
Treatment Option
5%
Tumor
41%
Yolk Sac
35%
